| Peter K. Maag |
Peter K. Maag is currently the Chief Executive Officer & Director at Kyverna Therapeutics, Inc. He is also an Independent Director at CareDx, Inc. Additionally, he holds positions as a Director at the Personalized Medicine Coalition and Blulake Ventures LLC. In the past, he served as an Independent Director at Miromatrix Medical, Inc. and as a Director at MolecularMD Corp. He has also held positions as a Director at Zuellig Pharma Corp. and as the Global Head-Novartis Diagnostics at Novartis International AG. Furthermore, he was the President of Novartis Vaccines & Diagnostics, Inc. and Novartis Pharmaceuticals. He also served as the Country President at Novartis Pharma AG and as the President of Novartis Korea Co., Ltd. Prior to his roles at Novartis, he worked as an Associate Principal at McKinsey GmbH & Co. KG. Dr. Maag holds a doctorate degree from Humboldt-Universität zu Berlin. |
| Marco Scheller |
Marco Scheller is currently working as the SVP & Clinical Operations at CareDx, Inc. He has a graduate degree from ETH Zürich Human Resources and an MBA from Columbia Business School. |
| Robert N. Woodward |
Robert N. Woodward is currently the Chief Scientific Officer at CareDx, Inc. He holds a doctorate degree from the University of Missouri and an undergraduate degree from Missouri State University. |
| Kashif Rathore |
Kashif Rathore is currently working as the Chief Of Patient & Digital Solution at CareDx, Inc. Previously, he worked as a Director at CommonWell Health Alliance, Inc. He holds an MBA from the University of Missouri, an undergraduate degree from the University of Central Oklahoma, and another undergraduate degree from the University of the Punjab. |
| Marica Grskovic |
Marica Grskovic is currently the Chief Operations Officer at CareDx, Inc. Prior to this, she worked as a Founding Scientist at iPierian, Inc. She holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg and The European Molecular Biology Laboratory. |
| Ashish Kothari |
Ashish Kothari is currently working as the Vice President-Medical Affairs at CareDx, Inc. He holds an MBA from MIT Sloan School of Management. |
| GS Jha |
GS Jha is currently working as the SVP, Chief Information & Security Officer at CareDx, Inc. Previously, he worked as the Global Chief Information Security Officer at Accuray, Inc. He holds a graduate degree from Wayne State University (Michigan), an MBA from Kellogg School of Management, and an undergraduate degree from Savitribai Phule Pune University. |
| Abhishek Jain |
Abhishek Jain is currently the Chief Financial & Accounting Officer at CareDx, Inc. since 2022. He is also a Member at The Institute of Chartered Accountants of India. Previously, he worked as a Controller-Sales & Marketing at Agilent Technologies, Inc. |
| Michael D. Goldberg |
Michael D. Goldberg founded OnCare, Inc. in 1995, where he worked as Chairman from 1999 to 2001 and Aaxion, Inc. in 1987, where he worked as President & Chief Executive Officer from 1987 to 1995. Mr. Goldberg also currently works at CareDx, Inc., as Chairman from 2021, DNAnexus, Inc., as Executive Chairman from 2011, Western Association of Venture Capitalists, as Director, California Institute for Regenerative Medicine, as Member-Governing Board, CureSearch for Children's Cancer, as Trustee, and Personalized Medicine Coalition, as Member. Mr. Goldberg also formerly worked at Nodality, Inc., as Executive Chairman & Chief Executive Officer from 2011 to 2012, Axion Pharmaceuticals, Inc., as President & Chief Executive Officer, Crescendo Bioscience LLC, as Chairman, iRhythm Technologies, Inc., as Chairman, Yor Labs, Inc., as Chairman, Genomic Health, Inc., as Director from 2001 to 2008, eHealth, Inc., as Independent Director from 2019 to 2021, The DNA Repair Co., as Director, Jasper Capital Holdings LLC, as Managing Director from 2000 to 2004, Medtronic Monitoring, Inc., as Director, Cetus Corp., as Director-Corporate Development from 1981 to 1985, eHealthInsurance Services, Inc., as Director from 1999 to 2007, Ventus Medical, Inc., as Director, Sevin Rosen Bayless Management Co., as Partner from 1985 to 1987, and MDV Management Co. LLC, as General Partner from 2005 to 2010. Mr. Goldberg received his undergraduate degree from Brandeis University and Masters Business Admin degree from Stanford Graduate School of Business. |
| John W. Hanna |
John W. Hanna is currently the President, Chief Executive Officer & Director at CareDx, Inc. He is also the Chairman-Reimbursement Workgroup Coalition at 21st Century Medicine, Inc. Previously, he served as the Chief Executive Officer & Director at Apton Biosystems LLC from 2021 to 2023. Prior to that, he was the GM-Endocrinology, Breast Cancer & Lymphoma at Veracyte, Inc. from 2011 to 2021. Mr. Hanna completed his undergraduate degree at Hampden-Sydney College in 2001 and obtained an MBA from the University of Miami School of Business in 2008. |
| Christine M. Cournoyer |
Christine M. Cournoyer is currently the Chairman at Spok Holdings, Inc. since 2022 and an Independent Director at CareDx, Inc. since 2019. Previously, she served as the Chairman & Chief Executive Officer at N-of-One, Inc. from 2012 to 2019. She also held positions as a Director at The Stride Rite Corp. from 2000 to 2007, GTECH Holdings Corp. from 2003 to 2006, and BJ's Wholesale Club, Inc. from 2008 to 2011. Additionally, she was the Managing Director-Database Division at Harte-Hanks, Inc. in 2006 and a Director at Emerson Hospital from 2012 to 2018. Earlier in her career, she was the Chief Information Officer at Lotus Development Corp. in 1994-1995, President & Chief Operating Officer at Authorize. Net Holdings, Inc. in 2003, President & Chief Operating Officer at Picis Clinical Solutions, Inc. from 2006 to 2010, and Vice President-Business Transformation at IBM Software Group from 1995 to 2002. She also served as the Vice President-Clinical Analytics at InGensa, Inc. in 2010-2011. Ms. Cournoyer holds a graduate degree from Northeastern University and undergraduate degrees from the University of Massachusetts and the University of Lowell. |
| George W. Bickerstaff |
George W. Bickerstaff founded M.M. Dillon & Co. LLC in 2005, where he is working as Managing Director & Partner from 2005. Mr. Bickerstaff also currently works at CareDx, Inc., as Independent Director from 2014, The International Centre for Missing & Exploited Children, as Director, GAVI Alliance, as Director, and various other companies. Mr. Bickerstaff also formerly worked at Innoviva, Inc., as Chairman from 2020 to 2023, Cardax, Inc., as Chairman from 2016 to 2017, Optical Academy LLC, as Chairman from 2017 to 2019, and various other companies. Mr. Bickerstaff received his graduate degree from Harvard University and undergraduate degree in 1978 from Rutgers State University of New Jersey. |
| Grace E. Colón |
Grace E. Colón is the founder of Pyranose Biotherapeutics, which was founded in 2012. She is currently the Executive Chairman at ProterixBio, Inc. since 2015, Chairman at Bloom Science, Inc. since 2023, and an Independent Director at CareDx, Inc. since 2019. Dr. Colón also holds positions as a Director at Biotechnology Innovation Organization, Voyager Therapeutics, Inc., MIT Corp. (United States), Women Corporate Directors, Latino Corporate Directors Association, and Massachusetts Institute of Technology. In her former positions, she served as the President, Chief Executive Officer & Director at InCarda Therapeutics, Inc. from 2013 to 2022, Director at Paradigm Diagnostics, Inc. from 2017 to 2019, Director at InterLink AI, Inc. from 2015 to 2019, Director at Cocoon Biotech, Inc. from 2016 to 2020, Vice President-Corporate Planning at Affymetrix, Inc. from 2000 to 2005, President-Industrial Products Division & SVP at Precigen, Inc. from 2010 to 2012, Head-Clinical Operations at Gilead Sciences from 2010 to 2012, Partner at New Science Ventures LLC from 2014 to 2016, Chief Operating Officer at International Genomics Consortium from 2001 to 2002, and Engagement Manager at McKinsey & Co., Inc. from 1996 to 2000. Dr. Colón obtained an undergraduate degree from the University of Pennsylvania and a doctorate degree from the University of Massachusetts. |
| Arthur A. Torres |
Arthur A. Torres is currently serving as Vice Chairman at California Institute for Regenerative Medicine, Vice Chairman at One Legacy Foundation, Independent Director at CareDx, Inc., Director at Covered California, and Member-Regents Board at the University of California. He previously served as Chairman at California Democratic Party from 1996 to 2009, President & Member at San Francisco Public Utilities Commission from 2010 to 2014, Director at San Francisco Municipal Transportation Agency from 2017 to 2020, and President at The University of Cincinnati Alumni Association. Mr. Torres completed his undergraduate degree from the University of California, Santa Cruz in 1968 and his graduate degree from UC Davis School of Law in 1971. |
| Hannah A. Valantine |
Hannah A. Valantine is the founder of Hav LLC, a company founded in 2021 where she holds the title of Principal. She is currently working as an Independent Director at CareDx, Inc., Pacific Biosciences of California, Inc., and BridgeBio Pharma, Inc., all since 2021. Additionally, she is a Professor at Stanford University School of Medicine since 1987 and a Member of the National Academy of Medicine (United States). Dr. Valantine completed her undergraduate and doctorate degrees at the University of London and also holds an undergraduate degree from Chelsea College. |
| Fred Ehrenkranz Cohen |
Fred Cohen is a member of the Investment Committee of Monograph and a Founder of Monograph. Prior to founding Monograph in 2020, Fred Cohen was Co-Founder and Senior Managing Director of Vida Ventures and Partner of TPG and Managing Partner of TPG Biotechnology having joined in 2001 to initiate TPG’s venture efforts in biotechnology and life sciences. Prior to that, Fred Cohen was a Professor of medicine, cellular and molecular pharmacology, biochemistry and biophysics and pharmaceutical chemistry at UCSF. In this context, he was Chief of the Division of Endocrinology and Metabolism and directed an active research program in the areas of prion biology, structure based drug design, bioinformatics and heteropolymer chemistry. Fred Cohen is a Fellow of the Institute of Medicine of the National Academies, the American Academy of Arts and Sciences, American College of Physicians, a member of the American Society for Clinical Investigation and the Association of American Physicians, and the recipient of several awards and honors including the Burroughs-Wellcome New Initiatives in Malaria Award, the LVMH Science Pour L’Art Prize (shared with Stanley Prusiner), a Searle Scholars Award and Young Investigator Awards from the Endocrine Society and the Western Society for Clinical Investigation. He graduated magna cum laude from Yale University in 1978 and received his D.Phil from Oxford University as a Rhodes Scholar in 1980, his M.D. from Stanford Medical School as an American Cancer Society Postdoctoral Fellow in 1984 and his internal medicine and endocrinology training at UCSF.
Fred Ehrenkranz Cohen received an undergraduate degree from Yale University, a doctorate from the University of Oxford and a doctorate from Stanford University. |
| William A. Hagstrom |
William A. Hagstrom was the founder of Crescendo Bioscience LLC, founded in 2007, where he held the title of President & Director in 2014. He is also the founder of Biolytx Pharmaceuticals Corp., founded in 2005, where he currently holds the title of Director. In addition, he is the founder of Octave Bioscience, Inc., founded in 2014, where he currently holds the title of Chairman. Mr. Hagstrom is also the founder of Altheus Therapeutics, Inc. . Mr. Hagstrom's current jobs include being an Independent Director at CareDx, Inc. since 2015, a Director at Cofactor Genomics, Inc. since 2018, and a Director at Zymetx, Inc. since 1994. His former jobs include being the Chief Executive Officer at Selexys Pharmaceuticals Corp., Chairman & Chief Executive Officer at Inoveon Corp. in 2001, Chairman, President & Chief Executive Officer at UroCor, Inc. from 1994 to 1998, and a Director at Prometheus Laboratories, Inc. He also served as a Director at Genalyte, Inc. from 2016 to 2020, and at Navican Genomics, Inc. from 2016 to 2020. Additionally, he held positions as Vice President-Scientific Products Division at Baxter International, Inc., Vice President at Becton, Dickinson & Co., and Vice President at American Hospital Supply Corp. He was also the President of Alpha BioPartners, Inc.Mr. Hagstrom's education includes an undergraduate degree from Bob Jones University. |
